There has been a steady decline in death rates among children and adolescent patients diagnosed with cancer (ages 1 to 19 years), minus gender or racial disparity, between 1999 and 2014, according to a new report from the National Center for Health Statistics.
There has been a steady decline in death rates among children and adolescent patients diagnosed with cancer, without gender or racial disparity, between 1999 and 2014, according to a new report released by the National Vital Statistics System of the National Center for Health Statistics. A significant finding of the report is that brain cancer has replaced leukemia as the leading cause of cancer-related death.
Pediatric cancers have seen a steady decline in mortality over the past decade, despite a slow increase in incidence of certain cancer types. For the current report, the researchers evaluated cancer death rates for children between ages 1 and 19 years for the period between 1999 and 2014. They compared death rates for both male and females, as well as white and black children and adolescents. The following are key findings from the report for that period:
Reference
Curtin SC, Miniño AM, Anderson RN. Declines in cancer death rates among children and adolescents in the United States, 1999—2014. NCHS data brief, no 257. Hyattsville, MD: National Center for Health Statistics; 2016.
Lack of Mutations Associated With Favorable Prognosis in MPN-U
April 25th 2024While the Dynamic International Prognostic Scoring System and bone marrow blasts may predict overall survival, the lack of certain mutations is also associated with a better prognosis for myeloproliferative neoplasm, unclassifiable (MPN-U).
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More
Data Back Neoadjuvant Combo vs Chemo Alone for Early-Stage NSCLC
April 24th 2024For patients with early-stage non–small cell lung cancer (NSCLC), combining neoadjuvant immune checkpoint inhibitors and platinum-based chemotherapy improves 2-year outcomes over chemotherapy alone, suggest findings of an extensive literature review and meta-analysis.
Read More